GlaxoSmithKline Research and Development Ltd.

GSK is a research based Pharma company with R&D facilities at multiple locations around the world including the UK, USA, Spain, France and China. It conducts fundamental and applied research towards new medicines across a wide range of therapeutic areas including oncology, inflammation, anti-infectives, respiratory, metabolic, cardiovascular, neuroscience, rare diseases and diseases of the developing world. Annual R&D spend is over £3.0bn and GSK currently has ca.13,000 R&D employees globally.

Website: GlaxoSmithKline

Staff involved in this project:
Prof. Mike Hann

Prof. Mike Hann is director and principal scientific investigator in chemical sciences (computational and medicinal chemistry, structural biology, biophysics and FBLD). Adjunct Professor, Dept of Chemistry, Imperial College, London.

Contact details

Please contact us at:

FRAGNET Coordinator
VU University Amsterdam
The Netherlands

Funded by

Marie Curie Actions

EU Horizon 2020

European Union